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Intestinal Neurod1 expression 
impairs paneth cell differentiation 
and promotes enteroendocrine 
lineage specification
Hui Joyce Li1, Subir K. Ray1, ning pan2,4, Jody Haigh3, Bernd fritzsch  2 & Andrew B. Leiter1*
Transcription factor Neurod1 is required for enteroendocrine progenitor differentiation and maturation. 
Several earlier studies indicated that ectopic expression of Neurod1 converted non- neuronal cells into 
neurons. However, the functional consequence of ectopic Neurod1 expression has not been examined 
in the GI tract, and it is not known whether Neurod1 can similarly switch cell fates in the intestine. We 
generated a mouse line that would enable us to conditionally express Neurod1 in intestinal epithelial 
cells at different stages of differentiation. Forced expression of Neurod1 throughout intestinal 
epithelium increased the number of EECs as well as the expression of EE specific transcription factors 
and hormones. Furthermore, we observed a substantial reduction of Paneth cell marker expression, 
although the expressions of enterocyte-, tuft- and goblet-cell specific markers are largely not affected. 
Our earlier study indicated that Neurog3+ progenitor cells give rise to not only EECs but also Goblet and 
Paneth cells. Here we show that the conditional expression of Neurod1 restricts Neurog3+ progenitors 
to adopt Paneth cell fate, and promotes more pronounced EE cell differentiation, while such effects are 
not seen in more differentiated Neurod1+ cells. Together, our data suggest that forced expression of 
Neurod1 programs intestinal epithelial cells more towards an EE cell fate at the expense of the Paneth 
cell lineage and the effect ceases as cells mature to EE cells.
Intestinal epithelial cells are divided into two main categories - absorptive cells and secretory cells. The absorptive 
cells include enterocytes and the secretory cells include enteroendocrine (EE), goblet, Paneth, and tuft cells1,2. 
All five cell types are derived from common multipotent intestinal stem cells. The expression of the atonal basic 
helix-loop-helix (bHLH) transcription factor 1 (Atoh1) initiates the differentiation of progenitor cells that are 
subsequently either fated to EE cell lineages by the downstream transcription factor, Neurogenin-3 (Neurog3, 
Ngn3), or to Goblet and Paneth cell lineages upon expression of the transcriptional repressor, growth factor 
independent-1(Gfi1)3–7. The differentiation of Tuft cells, on the other hand, adopts an Atoh1-independent path-
way involving high expression of Sox48,9. EE cells are hormone-producing cells scattered individually throughout 
the mammalian gastrointestinal tract. These cells comprise less than 2% of the total cell population. The matu-
ration and subtype specification of EE cells along crypt-villus axis require subsequent expression of a number of 
pro-endocrine transcription factors including Neurod1, Lmx1a, Nkx2-2, Insm1, Arx, Isl1 and Pax4/610–19.
The expression of Neurod1, a member of the bHLH family of transcription factors, is restricted to pancreatic 
islets, intestinal endocrine, stomach and neuronal cells. It regulates the expression of the insulin gene in pan-
creatic beta cells20,21, the secretin gene in small intestine22, and is capable to reprogram fibroblasts to a neuronal 
fate23–25 or Schwann cells into neurons26. In addition, Neurod1 (Nd1) also functions in governing cell cycle exit 
in photoreceptor lineage27 and can cause cell cycle arrest in in vitro cell culture28,29. Studies of Neurod1 targeted 
deletion mutants revealed its important functions in development and maintenance in several developing systems 
including the central nervous system30–33, the peripheral nervous systems (including the inner ear)34–37, the EE 
cells of the GI tract7,38,39, as well as the beta cells of the pancreas21,40. Neurod1 mutations have been found to cause 
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maturity-onset diabetes of the young and late-onset diabetes (Online Mendelian Inheritance in Man 606394)41. 
Recently, Neurod1 null mutations have been linked to ophthalmological phenotypes in humans42.
Neurod1 is a direct transcriptional target of Neurog3 in intestinal EECs43,44. Early studies have shown that 
Neurog3 is sufficient to induce an endocrine program when expressed in the intestine of transgenic mice6. 
Recent single-cell RNA profiling of individual intestinal epithelial cells categorized both Neurog3 and Neurod1 
as markers for immature45 or differentiating46 EEC precursors, suggesting a function of Neurod1 in early EEC 
differentiation. Another function of Neurod1 is its ability to reprogram other cell types into neurons through 
altering chromatin and transcription factor landscapes47. These results prompted us to investigate if expression 
of Neurod1 prior to Neurog3 can override the default function of Neurog3 in EE cell differentiation. To exam-
ine, we generated a Rosa26 Loxp-Stop-Loxp-Neurod1 (LSLNeurod1) mouse line that allows conditional Neurod1 
expression in Villin + cells (prior to Neurog3) by crossing with Vil-cre mice or Neurog3 + cells (concomitant with 
Neurog3) by crossing with Neurog3-cre mice. In this manuscript, we provide data demonstrating that conditional 
gain-of-function of Neurod1 prior to Neurog3 expression robustly increases EE cell numbers and this differentia-
tion process is limited to a subset of the gut progenitor cells that are competent to adopt an endocrine fate.
Results
Conditional expression of Neurod1 in the intestinal epithelial cells. To test if Neurod1 can switch 
cell fate and promote EEC differentiation in the developing intestinal epithelium, we generated a conditional 
gain-of-function Rosa26-loxp-Stop-loxp(LSL)Neurod1-IRES-eGFP mice line. A 1,280 bp full-length mouse Neurod1 
cDNA was cloned into the pEntry vector (Gateway®, Life Science). The conditional Rosa26LSLNeurod1 targeting 
vector was created through recombination of the pROSA26-DV1 destination vector with pENTR-mNeurod1 and 
targeted to the Rosa26 locus by electroporation into JM8F6 (C57BL/6) mouse embryonic stem (ES) cells48. We 
identified 7 out of 36 correctly targeted ES clones by PCR analysis using primers that cover both Rosa26 genomic 
sequence and the inserted transgenes (Fig. 1A). Clone A1 was chosen for C57BL/6 blastocyst injection to generate 
chimeras for germline transmission. ROSA-Loxp-STOP-loxpNeurod1 (LSLNeurod1) conditional mice were born viable 
and fertile.
To determine whether LSLNeurod1 mice can be used to induce Neurod1 expression by Cre-mediated recom-
bination in the small intestine, we crossed LSLNeurod1 mice with Villin-cre driver. Villin is expressed in most 
intestinal epithelial cells beginning at E13.549,50. Villin-cre-mediated excision of the Loxp-STOP-Loxp sequence 
allowed transcriptional read-through between the two LoxP sites in the Neurod1-IRES-eGFP bi-cistronic trans-
gene, resulting in Neurod1 and EGFP expression. The expression of Neurod1 and EGFP transgenes were deter-
mined by qPCR for transcripts, and immunofluorescent microscopy and immunoblotting for Neurod1 protein. 
As shown in Fig. 1B, compared with control Vil-cre;ROSAEYFP (LSLEYFP) mice, Neurod1 transcript in intestinal 
epithelial cells increased ~4.4-fold in Vil-cre;LSLNeurod1 mice whereas EGFP expression level is much lower than 
that of Vil-cre;LSLEYFP mice (11%). This is consistent with earlier findings that genes downstream of IRES are 
expressed at lower levels compared with the genes upstream of the IRES51,52.
The Neurod1 and EG/YFP proteins in the intestine were detected by co-immunostaining with Neurod1 
antibody and EGFP antibody which recognized both EGFP and EYFP proteins on duodenal tissues from 
Vil-cre;LSLEYFP and Vil-cre;LSLNeurod1 mice (Fig. 1C). As expected, we observed the green EYFP staining 
throughout crypt-villus structure of the intestine and sporadic Neurod1 nuclei staining (red arrow) in control 
Vil-cre;LSLEYFP mice (Fig. 1C, top left panel). In Vil-cre;LSLNeurod1 mice, we observed a significant increase 
in nuclear Neurod1-positive cells along the intestinal epithelium, mostly in the crypts from the duodenum 
(39% ± 11%) to the colon (32% ± 3%) (Fig. 1D). Approximately 10% of the Neurod1-positive cells appeared as 
epithelial ribbons in the crypt (Fig. 1C, bottom right panel). EGFP expression can be detected in both crypt and 
villi of those cells co-stained with Neurod1. We also analyzed proteins in whole cell lysates from Vilcre;LSLNeurod1 
mouse intestine that are recognized by the Neurod1 antibody in a Western blotting analysis (Fig. 1E). The anti-
body detected a single protein band (molecular weight of 50 kDa, the size of Neurod1 protein) with little or no 
background, further consolidating the above Neurod1 immunostaining results (Supplemental Figure).
Neurod1 expression in Villin+ cells profoundly increases EE cell numbers. To determine if the 
conditional Neurod1-expressing cells in the intestine of Vil-cre;LSLNeurod1 mice were endocrine cells, we stained 
intestinal sections with a pan-endocrine marker Chromogranin A (ChgA)53. A substantial increase in the num-
ber of ChgA+ cells in both the duodenal (11.1×) and colonic (11×) epithelium were observed, compared to 
Vil-cre;LSLEYFP control mice (Fig. 2A). In some crypt-villus structures, the increased ChgA+ EGFP + cell num-
ber was more pronounced, with nearly all cells in the epithelium expressing ChgA. The increased EE cell popu-
lation in Vil-cre;LSLNeurod1 mice suggested that Neurod1 is able to direct EEC differentiation when ectopically 
expressed. Contrary to sporadic appearance of EECs in the normal intestine, we observed ChgA+ EECs resided 
adjacent to each other (Fig. 2A,bottom right) in the intestines of Vil-cre;LSLNeurod1 mice, suggesting the loss of 
lateral inhibition function of Notch signaling by Neurod1, possibly through inhibiting Hes1 function54.
We next determined if Neurod1 increased the expression of genes associated with enteroendocrine function 
and differentiation by qPCR analysis. As shown in Fig. 2B, Neurod1 substantially increased the expression of 
many EEC hormones or associated genes including secretin (Sct), cholecystokinin (Cck), somatostatin (Sst), tryp-
tophan hydroxylase 1 (Tph1), gastric inhibitory polypeptide (Gip), and ghrelin; whereas glucagon transcripts did 
not show much change. The expression of a number of transcription factors associated with endocrine differenti-
ation in the GI tract, including Nkx2-2, Neurog3, Lmx1a, Insm1, Isl1 and Arx were found considerably increased 
along with Neurod1 (Fig. 2C), consistent with the increase of EEC numbers.
We examined the effects of Neurod1 on the expression of intestinal lineage specific genes including goblet 
cell (Muc2, Tff3, Klf4), enterocytes (ApoA4, Alpi, Fabp), Paneth cell (Lyz1, Dpp4) and Tuft cell (Dclk1, Siglec1) 
genes. qPCR assay shown in Fig. 3 revealed that the expression of Neurod1 in Villin+ cells had minimal effect on 
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Figure 1. Generation of a conditional Neurod1 mouse line at the ROSA26 locus. (A) In ROSA26 loci, the 
insertion of a loxP-PGK-neo-3xpA (STOP)-loxP sequence upstream of a knock-in Neurod1-IRES-eGFP gene 
prevents Neurod1 from being transcribed. Cre-mediated deletion of the STOP sequence upon crossing with a 
driver-mice (e.g, Villin-Cre mice), allows the ROSA26 promoter to drive expression of the Neurod1-IRES-eGFP 
bi-cistronic fusion transcript. PCR primers used for verification of the indicated locations of recombined clone 
are shown by arrows of different colors, e.g. red arrows (G1:G2 primers); green arrows (S1:S2 and S1:NDrev); 
and blue and purple arrows. (B) Expression of Neurod1 message is relatively high in Vil-cre;LSLND mice. 
Relative mRNA levels of Neurod1, EYFP or EGFP (normalized to β-actin) from indicated cells were shown. 
Values are mean ± SD (n = 3); *P ≤ 0.0001. (C) Representative double immunostaining for EYFP/EGFP 
(green) and Neurod1 (red) of duodenum tissues from Vil-cre; ROSA-YFP and Vil-cre;LSLNeurod1 mice. Bar 
graph shown summarized the %GFP+ cells stained for Neurod1 from indicated mouse intestine. p = 0.0082 as 
indicated. Scale bars = 50 µm. Red arrows pointed to nuclear Neurod1 staining. (D) Table summarized the % 
Neurod1+ cells along intestinal tract. ±represent standard deviation from at least three experimental replicates. 
The p values between each pair are: 0.45 (Duod to Colon), 0.72 (Ileum to Colon) and 0.33 (Duod to Ileum). 
These p values are >0.05, indicating no significant difference among the three testing groups. (E) Expression of 
Neurod1 protein in Vil-cre;LSLNd1 mice. Equal amounts of total protein from cell lysates of the duodenum of 
Vil-cre;YFP and Vil-cre;LSLNeurod1 mice (top panel: 60 ug protein/lane; bottom panel: 20 ug protein/lane) were 
separated on SDS-PAGE followed by immune-blotting with Neurod1 antibody (top panel, black arrow) or Actin 
antibody (bottom panel).
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expressions of genes specific for enterocytes, goblet and Tuft cells. However, expression of the Paneth cell specific 
maker genes Lyz1 and Dpp4 were reduced by approximately 60% and 50% respectively. These results suggested 
that upon Neurod1 expression in Paneth cell progenitors, their maturation is either blocked or shunt towards 
EEC lineage, possibly via a well-known negative feedback loop of Neurod1 on controlling Atoh1 expression level 
in developing system55,56.
However, not all Neurod1 expressing cells were ChgA+ (Fig. 4A, green arrow). We observed a 54.4% ± 8% of 
cells stained for Neurod1 that co-stained with ChgA in the intestines of ROSA26-LStopLNeurod mice strain.
Neurod1 induction of the endocrine lineage depends on the differentiation stage. All five 
cell types in adult intestinal epithelium are constantly regenerated from multipotential ISCs. The expression of 
Neurog3 represents one of the earliest stages in the initiation of EEC specification whereas the subsequent expres-
sion of its target, Neurod1, occurs at a later stage of EEC differentiation when cells are restricted to an EEC cell 
fate7. To determine the effect of Neurod1 on cell fates in Neurog3+ early EEC progenitors or Neurod1+ late EEC 
precursors, we crossed ROSA-LSLNeurod1 mice with Neurog3-cre or Neurod1-cre mice respectively. As shown 
in Fig. 4, when Neurod1 expression was activated in Neurog3+ progenitor cells by the Neurog3-cre driver, we 
observed a small increase (~2 fold) in ChgA+ cell numbers. However, ectopic Neurod1 expression in Neurod1+ 
cells resulted in a 58% reduction of ChgA+ EEC numbers (Fig. 4B). This suggested a potential function of 
Neurod1 in promoting EEC differentiation and that may depend on the competency of the target progenitor cells.
Neurod1 expression in Neurog3 cells blocks their fate towards paneth cells. We further ana-
lyzed the cell fates of Neurod1+ expressing cells in the intestine of Neurog3-cre;LSLNeurod1 mice. Unlike 
Neurog3+ cells in Neurog3cre;ROSA-EYFP mice that give rise to all three types of secretory cells, including 
Figure 2. Expansion of EECs with conditional Neurod1 expression in Villin+ cells. (A) Representative double 
immunostaining for EYFP/EGFP (green) and ChgA (red) of Crypt and Villus compartments from duodenum 
and colon samples of Vil-cre;LSLEYFP and Vil-cre;LSLNeurod1 mice. Bar graph on the right summarized the % 
of ChgA+ cells in the intestines between two mouse strains as indicated. The p values shown in the graph were: 
0.0005 for Duodenum and 0.0001 for Colon. Nuclei were stained with Dapi. Scale bars = 50 µM. (B,C) Neurod1 
in Villin+ cells increased the expression of gastrointestinal hormones (B) and EEC-specific transcription factors 
(C). Bar graph represents normalized (normalized to β-actin) mRNA levels of the indicated genes. Values are 
mean ± SD (n = 3). In B, P value of all hormone pairs ≤0.001; in C, *P = 0.21, the rest P ≤ 0.001.
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Paneth cells (~30%), goblet cells (~25%), and EEC cells (~40%)57, the Neurod1 expressing Neurog3+ cells in 
Neurog3-cre-LSLNeurod1 mice gave rise only to EEC and goblet cells (Fig. 5A, yellow arrow). Tuft cells, another 
secretory cell type present in the small intestine, differentiate from an Atoh1-independent origin8. We observed 
an increase of ChgA+ EEC cell numbers (77% for Neurog3cre;LSLNeurod1 and 36% for Neurog3creERT2; 
LSLNeurod1 respectively). The Muc2 + EGFP+ goblet cell numbers did not show significant difference upon con-
ditional Neurod1 expression in Neurog3 progenitor cells (p = 0.25, Fig. 5A). We also crossed ROSA-LSLNeurod1 
mice with the Neurog3-cre-ERT2 inducible cre driver line to temporally induce Neurod1 expression in Neurog3+ 
cells in adult mice. We observed a 35.5% increase in ChgA+ cells (p = 0.025), whereas a significant reduction of 
goblet cell number was seen (p = 0.002, Fig. 5B). The discrepancy of Neurod1 effect on goblet cell differentiation 
may depend on the timing of Neurod1 expression.
However, we did not observe EGFP-expression in Lyz+ Paneth cells (Fig. 5A). Consistent with what we 
observed in Neurog3-cre; LSLNeurod1 mice, we did not detect the presence of EGFP + Lyz + cells in the induced 
adult intestines (Fig. 5B). These data suggested that conditional Neurod1 expression in Neurog3 + secretory pro-
genitors blocked their differentiation to Paneth cells in both developing and adult mice.
Discussion
Here we generated a new Neurod1 gain-of-function mouse line that enables conditional expression of Neurod1 
in Cre expressing cells at different stages of EEC maturation. Whether the intestinal cells would respond to 
ectopic Neurod1 expression has not been examined. We reported here a substantial increase in the EEC num-
bers when Neurod1 was conditionally expressed in Villin-Cre+ intestinal cells. Expression of Neurod1 in 
Neurog3-Cre+ cells only led to a modest increase in EEC numbers whereas reduction in EEC numbers was seen 
in Neurod1-Cre+ cells. As with the recent findings of Neurod1 as a pioneer factor in the nervous system, our data 
suggest Neurod1 may function similarly in EEC differentiation and the effects are dependent on differentiation 
stage.
Sequential expression of bHLH transcription factor Neurogenin 3 and its target Neurod1 is a hallmark of 
enteroendocrine (EE) lineage specification and maturation. We first considered Neurog3+ EEC progenitors since 
Neurog3+ cells are multipotent early EEC progenitor cells46,57 that give rise to EEC, Goblet and Paneth cells, 
although majority of Goblet and Paneth cells arise from Gfi+ secretory progenitors. We observed that the expres-
sion of Neurod1 resulted in only ~2-fold increase of EEC numbers compared to WT, with no Neurod1 or ChgA 
epithelial ribbon staining. The increased EEC numbers may be from those Neurog3+ cells that fate to Paneth 
cells. Our data also suggested that EEC and Paneth cells arise at least in part from common progenitors, in line 
with recent lineage tracing experiments46.
Early lineage tracing in Villin-cre/ROSA26EGFP mice detected wide expression of EGFP throughout the whole 
intestinal epithelium, including all epithelial cells from intestinal stem cells at the crypt base and all types of matured 
epithelial cells. However, in the intestine of Villin-cre/LSLNeurod1 mice, approximately 30% to 39% of epithelial cells 
stained for Neurod1 (Fig. 1D), mostly detected in cells located in the crypt and lower villus (Fig. 1C). This may be due to 
the shorter half-life of Neurod1 leading to decreased Neurod1 along crypt-villus structure. The sensitivity of Neurod1 
antibody used in Immunostaining may not be able to detect low levels of Neurod1. Neurod1+ ribbon structure can 
only be seen in ~10% of the whole intestine. A number of factors may contribute to such a discrepancy on the expres-
sion of transgenes between Vil-cre/L-Stop-LNeurod1 and Vil-cre/ROSA26R. Recent studies have shown that floxed alleles 
have different sensitivities to Cre-mediated recombination58. The recombination efficiency between different reporter 
alleles varies greatly on the nucleotide sequences flanking the LoxP sites, distance between loxP sites, the chromosomal 
location of floxed alleles and the levels of Cre activities.
Figure 3. The effects of Neurod1 expression in Villin+ cells on the differentiation of non-EEC cell lineages. 
Neurod1 in Villin+ cells did not affect marker gene expression for goblet cells and enterocytes. A reduction of 
Paneth cell marker expression was observed. Bar graph represents normalized (normalized to β-actin) mRNA 
levels of the indicated genes. Values are mean ± SD (n = 3), **P ≤ 0.0001; No substantial differences were seen 
of exogenous Neurod1 expression on other lineage marker expression including enterocyte, goblet and tuft cells 
(P ≥ 0.05).
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Unlike normal EECs present as individual mucosal endocrine cells, the ChgA + epithelial ribbon structure 
in the intestines of Vil-cre+; LSLNeurod1 mice suggested certain Villin + Neurod1+ cells are stem cells. The 
Intestinal cell types including EECs arise from intestinal stem cells (ISCs) located at the crypt base. The exist-
ence of two stem cell pools in the intestinal crypt is well recognized: actively Lgr5+ cycling columnar basal 
cells (CBCs) and quiescent Bmi1+ +4 position slow cycling stem cells59,60. Bmi1+ cells have been suggested as 
pre-terminal enteroendocrine cells61. Intestinal stem cells in each pool are highly heterogeneous. In addition, 
other slow cycling stem cells have been identified to express other ISC markers such as Lrig162, Hopx63, mTert64. 
The identities and relationship of each type of stem cells with distinct ISC markers are not completely clear even 
after single-cell RNA sequencing of some progenitor pools that has defined hierarchical classification of some 
subpopulations46. Further studies to express Neurod1 in mouse intestine using different progenitor and stem cell 
marker specific Cre drivers such as Atoh165, Lgr566, Bmi160 and Lrig162 may shed more light on the identities of 
those Neurod1 susceptible early progenitor cells.
Similar to myogenic determining factor MyoD that trans-differentiate fibroblasts into functional skeletal mus-
cle cells67–69, Neurod1 is able to direct neuron conversion from human cultured fibroblasts23 or in vivo endoge-
nous mouse astrocytes in the brain and spinal cord70,71 when exogenously expressed. The interaction of Neurod1 
with Atoh1 plays a role in neurosensory cell differentiation during inner ear development and regeneration37,72,73. 
The potential of Neurod1 to induce differentiation - including fate switching - in immature cells, suggests that it 
could play a major role in direct differentiation of cells, short-circuiting the current attempts to generate differen-
tiated cells out of induced pluripotent stem cells. Consistent with this idea, recent studies showed that Neurod1 
can function as a pioneer factor and its expression in microglia can directly convert microglia to functional 
Figure 4. Conditional Neurod1 expression in different EEC differentiation stages. Targeted Neurod1 
expression in Neurod1+, Neurog3+ and Villin+ cells were driven by Neurod1-cre, Neurog3-cre and Vil-cre 
mice respectively. (A) Duodenum sections from WT, Neurod1-creLSLNeurod1, Neurog3-creLSLNeurod1 and 
Vil-creLSLNeurod1 were stained with antibodies against ChgA (red) and Neurod1(green). DAPI (blue) stains 
for nuclei. Scale bar = 50 µM. (B) The number of ChgA+ cells in the intestines of indicated Cre-LSLNeurod1 
mice were quantified as shown in the bar graph. Error bars represent standard deviation from at least three 
experimental replicates. *P = 0.007; **P = 0.004, ***P ≤ 0.0001.
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neurons in the adult striatum47. Microglial cells are extremely plastic; it can undergo a variety of structure changes 
upon different stimuli. Like other pioneer factors, Neurod1 induces global transcriptional changes when exog-
enously expressed in microglia by occupying chromatin loci to modulate chromatin structure. Our preliminary 
results using a ChIP-seq assay identified over 7,500 substantial Neurod1 occupied loci in STC neuroendocrine 
cells (https://doi.org/10.1016/S0016-5085(17)30723-0), consistent with recent publication showing that nearly 
3000 loci were regulated by Neurod174. Taken together, our data suggest a broader role of Neurod1 as a possible 
pioneer factor in EEC differentiation.
We previously showed by lineage tracing using Neurog3-cre;ROSA-EYFP mice that Neurog3+ cells gave rise 
to not only EEC, but also Goblet and Paneth cells57. Here we found that the gain-of-function of Neurod1 expres-
sion in Neurog3+ cells blocked Neurog3+ cells from differentiating into Paneth cells (Fig. 5). Similarly, when 
Neurod1 was expressed in Villin+ cells in Vilcre;LSLNeurod1 mice, we observed a considerable decrease in Paneth 
cell marker expression and no effect to Goblet and Tuft cell markers (Fig. 3). These results suggest that Neurod1 
expression restricts intestinal epithelial cells towards EECs inhibiting Paneth cell lineage.
The canonical Wnt signaling pathway plays an important role not only in stem cell maintenance but also in Paneth 
cell differentiation and maturation processes75. Conditional expression of non-degradable mutant beta-catenin (exon3 
deletion) in Neurod1+ EECs failed to activate wnt pathway, while the wnt activation occurred when the same mutant 
beta-catenin was expressed in Neurog3+ cells76. The onset of Neurod1 expression resulted in the failure of Wnt activa-
tion and inhibition of its target gene c-Myc expression76. In fact, a number of tissue specific transcription factors have 
been described to interact with β-catenin and inhibit Wnt activation in a number of developmental systems includ-
ing chondrogenesis and hematopoiesis77–83. Those interactions lead to blocking of differentiation through disrupting 
β-catenin/TCF4 complex (Icat, Hif1a, Cdx2) or its binding to DNA (Runx3, Pdx1, Hbp1) or preventing coactivators 
recruitment (Klf4). Neurod1 might adopt similar mechanism in inhibiting Wnt activation. This may represent a novel 
yet unappreciated role of Neurod1 in mediating transcriptional repression of target gene expression.
Figure 5. Ectopic expression of Neurod1 in Neurog3+ cells in the intestine prevents Neurog3+ progenitor 
cells from becoming Paneth cells. Co-Immunofluorescent staining detected EGFP and the Paneth cell marker, 
lysozyme (Lyz), or goblet cell marker (Muc2) in the duodenum tissues of either Neurog3-cre-LSLNeurod1  
(A) or Tamoxifen-inducible Neurog3-creERT2;LSLNeurod1. (B) Scale bars represent 50 µm. Bar graphs on the  
left summarized the % GFP+ intestinal epithelial cells stained for EEC (ChgA), Goblet (Muc2) and Paneth 
(Lyz) cells. Error bars represent standard deviation from at least three experimental replicates. P values were 
indicated in the graph.
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Methods
Mice. The Institutional Animal Care and Use Committee (IACUC) at the University of Massachusetts Medical 
School approved all experimental protocols of our vertebrate animal studies in accordance with National Institute 
of Health (NIH) guidelines. All mice were housed in AALACC certified facilities, under constant temperature, air 
pressure and specific pathogen-free conditions and a 12-hour light cycle.
For lineage tracing experiments, we used previously described Cre-driver mouse lines including Vil-cre49, 
Neurog3-cre57, Neurog3-creERT2 and Neurod1-cre84. To induce Cre activity in Neurog3creERT2 compounded mice, 
4-week old mice were treated with 2 mg tamoxifen (Sigma, T5648) dissolved in corn oil with one intraperitoneal 
injection daily for 5 consecutive days. Tissues were harvested and analyzed 7 days later.
Targeting loxp-neurod1-loxp ES cells. A pEntry-mNeurod1 plasmid was generated by cloning full-length 
mouse Neurod1 cDNA into the pEntry vector (Gateway). A Gateway-compatible pROSA26 Destination Vector 
(pROSA26-DV1 LMBP 6350)48 was used to generate a Rosa26 locus targeting vector for conditional overexpres-
sion of Neurod1 with an ires-EGFP reporter. Clones were verified by both enzymatic digestion and sequencing. 
A linearized ROSA26-DV1-mNeurod1 plasmid was electroporated into C57BL/6 derived JM8.F6 ES cells85. 
G418-resistant ES-cell clones were screened by PCR using primers set at both 5′ ROSA26 and 3′ covering loxP site: 
G1: 5′-TAGGTAGGGGATCGGGACTCT-3′; and G2: 5′-GCGAAGAGTTTGTCCTCAACC-3′ to generate a 1.3 kb 
fragment. PCR-positive clones were further verified with additional PCR reactions using both Neurod1 internal and 
external ROSA-3′UTR primers and EGFP primers as indicated in Fig. 1: S1: ATCATGTCTGGATCCCCATC; S2: 
GGGGCGGAATTCGATATCAAG. mND552rev: TGGTAGTGGGCTGGGACAAACCTTT. Rosa3′UTR-DV1-for: 
AACAGAGGCTGTTGGTACTAGTGGC; Rosa3′UTRrev: AGCACCAAATGTGGTGCAGT. EGFP-for: AAG TTC 
ATC TGC ACC ACC G; EGFPrev: TCC TTG AAG AAG ATG GTG CG.
Generation of chimeras. The chimeras were generated by our Transgenic Core facility (https://www.umassmed.
edu/tkomouse/). In brief, obtained positive JM8.F6 ES cell clones were injected into albino C57BL/6Jtyrc-Brd blastocysts. 
The resulting chimeras were bred with Albino C57BL/6Jtyrc-Brd mice. Germline transmitted transgenic mice that carried 
targeted allele were selected by fur color and confirmed by genotyping using PCR analysis of DNA isolated from mice 
ear snips. Primer pairs S1:mND552rev shown in Fig. 1 were used in the PCR reaction.
Intestinal epithelial cell isolation. Mouse intestinal crypt and villus isolation were performed according 
to a published protocol with modifications86. In brief, mice were euthanized by CO2 and cervical dislocation. The 
small intestines were flushed with ice-cold 1xPBS and everted on a 4 mm rod. Intestinal tissues were cut into 2 cm 
pieces and incubated in chelating buffer [pH = 7.3: 1xD-PBS (1 mM CaCl2, 0.5 mM MgCl2, 8 mM Na2HPO4, 137 
mM-NaCl, 1.5 mM-KH22PO4, 2.7 mM-KCl), 1 mM-DTT, 1 mM EDTA] at 4 °C with constant shaking for 30 min. 
The cells were released as large sheets of villus cells. The tissues were transferred to fresh chelating buffer and were 
vigorously shaken to release crypts into the media. The collected villus and crypt portions were filtered through a 
70 µm Cell Strainer and pelleted at 200 rpm for 5 minutes with low brake speed. The villus and crypt pellets were 
resuspended in Trizol (Invitrogen, Inc.) for RNA extraction.
RNA isolation and qPCR analysis. RNAs were prepared with RNeasy Mini kit (Qiagen). In-column DNA 
digestion was performed to remove possible DNA contamination using RNase-free DNase (Qiagen). cDNAs were 
prepared using the Maxima First-Strand cDNA synthesis kit for RT-qPCR (Thermo Scientific). qPCRs were per-
formed according to standard protocol using the Light Cycler (BioRad). Results are given as relative expression 
normalized to housekeeping gene beta-actin. Primer sequences are available upon request.
Immunofluorescence staining and western blotting. Intestinal tissues were fixed in 4% formal-
dehyde and embedded in OCT for frozen sections. For immunofluorescence analysis, the following primary 
antibodies were used: goat anti-EGFP (1:400, Novus Biologicals: NB100-1770), rabbit anti-Chromogranin A 
(1:1000, Immunostar: #20085), rabbit anti-Muc2 (1:500, Santa Cruz: H-300), and rabbit anti-Lyz (1:500, Zymed 
Laboratories: 18-0039), rabbit anti-Neurod1 (1:250, Abcam: Ab109224). Alexa Fluor 488 or 594 conjugated 
secondary antibodies were used at a dilution of 1:800. Intestinal Alkaline Phosphatase activities were detected 
according to the manufacturer’s protocol (Vector Red AP Substrate Kit, Cat. #: SK-5100). Images were aquired 
using a Nikon Eclipse E600 microscope with imaging software of NIS-Elements AR 4.30.02.
Western blotting was performed as previous describe22. In brief, equal amount of proteins was separated by 
SDS-PAGE and eleterotransferred onto a nitrocellulose membrane. Nonspecific binding to the membrane was 
blocked with a 3% milk solution in phosphate-buffered saline (PBS) containing 0.1% NP-40 prior to incubation 
with an anti-Neurod1 antibody (1:1,000; Abcam clone #Ab109224) or anti-actin antibody (1:2,000, Santa Cruz: 
sc-1616 HRP). An enhanced chemiluminescence (ECL) kit (Amersham) was used for detection of protein.
Statistical analysis. Pair-wise comparisons were analyzed by the Student’s t test. The statistical significance 
of pairwise comparisons shown on the bar graph were indicated with P ≤ 0.05 as significant and P > 0.05 as 
non-significant.
Data availability
No datasets were generated or analyzed during the current study.
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